Barclays’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
106,862
-228
| -0.2% | -$7.15K | ﹤0.01% | 1883 |
|
|
2025
Q1 | $3.18M | Buy |
107,090
+86,465
| +419% | +$2.57M | ﹤0.01% | 1724 |
|
|
2024
Q4 | $608K | Buy |
20,625
+19,663
| +2,044% | +$580K | ﹤0.01% | 2935 |
|
|
2024
Q3 | $30K | Buy |
962
+27
| +3% | +$842 | ﹤0.01% | 4005 |
|
|
2024
Q2 | $32K | Sell |
935
-6,813
| -88% | -$233K | ﹤0.01% | 3807 |
|
|
2024
Q1 | $503K | Buy |
7,748
+167
| +2% | +$10.8K | ﹤0.01% | 2832 |
|
|
2023
Q4 | $518K | Sell |
7,581
-57,474
| -88% | -$3.93M | ﹤0.01% | 2976 |
|
|
2023
Q3 | $3.38M | Sell |
65,055
-132,086
| -67% | -$6.85M | ﹤0.01% | 1364 |
|
|
2023
Q2 | $11.8M | Sell |
197,141
-5,843
| -3% | -$350K | 0.01% | 848 |
|
|
2023
Q1 | $10M | Buy |
202,984
+5,856
| +3% | +$290K | ﹤0.01% | 804 |
|
|
2022
Q4 | $11.3M | Buy |
197,128
+196,456
| +29,235% | +$11.2M | 0.01% | 797 |
|
|
2022
Q3 | $32K | Sell |
672
-104
| -13% | -$4.95K | ﹤0.01% | 3789 |
|
|
2022
Q2 | $29K | Sell |
776
-332
| -30% | -$12.4K | ﹤0.01% | 3951 |
|
|
2022
Q1 | $33K | Buy |
+1,108
| New | +$33K | ﹤0.01% | 4159 |
|